AKT1 and neoplasm: As shown in Fig. 1F and Fig S1B, administration of CYH33 at 20 mg/kg significantly inhibited the growth of HN4 xenografts, which was accompanied with decreased level of phosphorylated Akt and Ki-67 staining in tumor tissues.